Cosmos Health Continues U.S. Expansion with Launch of Oliv18, Targeting Cardiovascular and Antioxidant Categories

Oliv18™ expands the 18 Series with a USDA and EU organic certified, 100% solvent-free, whole olive polyphenol formulation from the Moroccan Saharan desert Hydroxytyrosol — the key active in Oliv18™ — is the highest ORAC polyphenol A single 250 mg daily dose meets EFSA's 5 mg/day hydroxytyrosol minimum dose for protection against LDL oxidation A single daily dose equivalent to approximately 11 teaspoons of good quality extra virgin olive oil — compared to an average of half a teaspoon per day in the U.S. Targeting the multibillion cardiovascular health and antioxidant markets, initially in the United States and globally thereafter — within a combined global market landscape projected to exceed $33 billion by 2035 CHICAGO, June 05, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. (“Cosmos Health” or the “Company”) (NASDAQ:COSM) , a diversified, vertically integrated global healthcare group, today announced the U.S. launch of Oliv18™, further expanding its science-driven 18 Series nutraceutical platform into cardiovascular and antioxidant categories. Scientific Background Oliv18™ is formulated with a whole olive polyphenol extract derived from the fruit and leaf of olive trees cultivated in the Moroccan stretch of the Saharan Desert.